Serum immune parameters as predictors for treatment outcomes in cervical cancer treated with concurrent chemo-radiotherapy
This study demonstrated that the baseline SII, SIRI, and LDH levels can be used to accurately and effectively predict the treatment outcomes after CCRT and long-term prognosis. Our results may offer additional prognostic information in clinical, which helps to detect the potential recurrent metastasis in time.
Authors
- Yu Gu (ORCID: https://orcid.org/0000-0002-5683-8078)
- Lihua Chen (ORCID: https://orcid.org/0000-0001-7149-6056)
- Chen Li (ORCID: https://orcid.org/0000-0002-8527-1680)
- Xinran Li (ORCID: https://orcid.org/0000-0001-8988-7223)
- Fuquan Zhang (ORCID: https://orcid.org/0000-0002-1379-1919)
- Weilin Chen (ORCID: https://orcid.org/0009-0005-8131-0135)
- Yang Xiang (ORCID: https://orcid.org/0000-0002-7324-2954)
- Yingying Lin (ORCID: https://orcid.org/0000-0001-9750-2995)
- Yuncan Zhou
- Ke Hu (ORCID: https://orcid.org/0000-0003-3462-5378)
Institutions
- Fujian Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
- Zhangzhou Municipal Hospital of Fujian Province (CN)
- Fuzhou Maternity and Child Health Care Hospital (CN)
Publication Details
- Journal
- Chinese Medical Journal
- Published
- 2025-11-07
- DOI
- https://doi.org/10.1097/cm9.0000000000003553
- Citations
- 1
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.06